Impact of chronic kidney disease on 2‐year clinical outcomes in patients treated with 6‐month or 24‐month DAPT duration: An analysis from the PRODIGY trial
Sign Up to like & getrecommendations! Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26921
Abstract: To assess whether moderate‐to‐severe CKD is a treatment modifier for benefit or harm in patients randomly allocated to 24‐month versus 6‐month DAPT. read more here.
Keywords: chronic kidney; month dapt; impact chronic; month ... See more keywords
Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2
Sign Up to like & getrecommendations! Published in 2020 at "Cardiovascular Intervention and Therapeutics"
DOI: 10.1007/s12928-020-00719-6
Abstract: The ultra-short dual antiplatelet therapy (DAPT) followed by P2Y12 inhibitor monotherapy might be promising after percutaneous coronary intervention (PCI). However, CYP2C19 loss-of-function (LOF) alleles have been reported to diminish the effect of clopidogrel, and clopidogrel… read more here.
Keywords: month dapt; antiplatelet therapy; dual antiplatelet; month ... See more keywords
A3825 Effectiveness and implications of six-month dual antiplatelet therapy following implanting drug-eluting stents: a systematic review and network meta-analysis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000548609.51504.b1
Abstract: Objectives: We aimed to compare and rank different durations of DAPT after DES placement for various clinical endpoints. Methods: We did a network meta-analysis comparing short-term (⩽6 months)versus standard-term (12 months)versus long-term (≥18 months). We… read more here.
Keywords: term; month dapt; month; network meta ... See more keywords